Evaluating the role of postoperative long-acting somatostatin analogue therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking
Endocrine Abstracts · 04.03.2026
DOI: 10.1530/endoabs.116.c46 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Abstracts, online erschienen am 04.03.2026. Verfasst von MD Theodoros Michelakos, und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Michelakos,, M. T., Tobias,, M. J., Azar, Abou, M. S., Polite,, M. B., MD, Millis,, J. M., MD, Liao,, C., & Keutgen,, M. X. M. (2026). Evaluating the role of postoperative long-acting somatostatin analogue therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking. Endocrine Abstracts. https://doi.org/10.1530/endoabs.116.c46
Vancouver
Michelakos, MT, Tobias, MJ, Azar, Abou MS, Polite, MB, MD, et al. Evaluating the role of postoperative long-acting somatostatin analogue therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking. Endocrine Abstracts. 2026. doi:10.1530/endoabs.116.c46
BibTeX
@article{Michelakos2026,
author = {Michelakos,, MD Theodoros and Tobias,, MD Joseph and Azar and Abou, MD Sara and Polite,, MD Blase and MD and Millis,, J Michael and MD and Liao,, Chih-Yi and Keutgen,, MD Xavier M},
title = {Evaluating the role of postoperative long-acting somatostatin analogue therapy in patients with metastatic neuroendocrine tumors undergoing surgical debulking},
journal = {Endocrine Abstracts},
year = {2026},
doi = {10.1530/endoabs.116.c46}
}
EUVIMED